To identify downstream effectors involved in NSUN2-mediated activation of PI3K/AKT and ERK/MAPK signaling, we assessed potential targets with hypermethylated-m5Cs in ESCC tumors. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.